Up almost 32% since listing, Mankind Pharma draws rush of 'buys'
The company's stock has surged more than 60 per cent since listing, driving its market value to about $8.5 billion
Source: business-standard.com
Ankind Ipo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ankind Ipo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ankind Ipo Today - Breaking & Trending Today
Stocks to Watch: Aarti Industries, Lupin, Pidilite, Mankind, Nazara Tech, and Others
Stocks to watch: Shares of firms like Aarti Industries, Lupin, Pidilite, Mankind Pharma, Nazara Tech, and others will be in focus on Tuesday's trade.
Source: news18.com
Mankind Pharma shares extend gain after solid listing; should you stay put or book profits?
The bullish momentum in Mankind Pharma continued even after listing as the stock advanced another 9 per cent to Rs 1,414, extending the overall gains to about 31 per cent.
Source: businesstoday.in
Mankind Pharma share bumper listing: Stock debuts at 20% premium; what should investors do?
Mankind Pharma share price: Mankind Pharma shares debuted at a 20% premium on Dalal Street today. The stock of India’s fourth largest pharmaceutical company got listed at Rs 1,300 on BSE and NSE, against the issue price of Rs 1,080. Watch this Visual Story to know what investors should do with the stock.
Source: businesstoday.in
Mankind Pharma shares make solid market debut, list at 20% premium over issue price
The IPO of Mankind Pharma was open for subscription between April 25-27 in the price range of Rs 1,026-1,080 per share as the company raised 4,326 crore and issue was overall booked 15.32 times.
Source: businesstoday.in